U.S. Securities and Exchange Commission
Disbarred Attorney Charged With Microcap Fraud
Richard Rubin, who formerly worked for the SEC, allegedly collaborated with a Florida lawyer to issue phony opinion letters for microcap stock offerings.
SEC Proposes Equity Pay for Tech Firm Gig Workers
A proposed rule change would allow internet platform workers to "participate at a measured level in the growth of the companies that their efforts support."
CEO of Digital Ad Startup Charged With Fraud
Andrew Chapin falsely represented to investors that well-known brands including Nike and Patagonia were using his company Benja's services, the SEC says.
Feds Subpoena Nikola as Part of Fraud Probe
The electric vehicle maker has been under scrutiny since a short-seller accused it of misleading investors about its technology.
SEC Fines From Enforcement Hit Record $4.68B
The number of new enforcement actions fell 17% this year but the SEC opened more than 150 COVID-related inquiries and investigations.
Cybersecurity Tycoon Accused of Touting ICOs
The SEC says John McAfee promoted initial coin offerings without disclosing that issuers paid him more than $23 million for his promotions.
Three Former Manitex Execs Charged With Fraud
Former CFO Michael Schneider and two colleagues allegedly engaged in schemes that resulted in the crane maker’s revenue and profit being overstated.
Kroll Fined $2M for Violating Credit-Rating Rules
The SEC says Kroll failed to comply with rules for determining the ratings of commercial mortgage-backed securities and CLO Combo Notes.
Ex-Amazon Employee Accused of Insider Trading
The manager in Amazon's tax department allegedly made illegal trades with two family members ahead of the company's earnings announcements.
Interface, ex-CFO Fined $5M for Inflating Earnings
The SEC says the carpet maker adjusted its accounting when its forecasts indicated it would likely fall far short of analysts' earnings estimates.
Biotech Exec Charged With COVID Test Fraud
The SEC says Arrayit President Mark Schena falsely claimed the company had developed a test and it was awaiting emergency FDA approval.